Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 71247-130

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 71247-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Innogenix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labetalol 100 mg (Labetalol Label1)

Label for Labetalol Hydrochloride Tablets, USP 100 mg, film-coated oral tablets. The package contains 100 tablets and is labeled by Innogenix, Inc. Additional panel text includes usage and storage instructions, barcode, and a note indicating no varnish.*

FDA Label Image

Labetalol 200 mg (Labetalol Label2)

Label for Labetalol Hydrochloride Tablets, USP 200 mg oral film-coated tablets. The label indicates 100 tablets per container and shows the labeler as Innogenix, Inc. Additional details include storage instructions and a barcode.*

FDA Label Image

Labetalol 300 mg (Labetalol Label3)

Label for Labetalol Hydrochloride Tablets, USP 300 mg oral film-coated tablets by Innogenix, Inc., containing 100 tablets per bottle. The label displays the NDC 71247-130-01 and advises Rx only. It includes storage instructions, safety warnings, and a barcode.*

FDA Label Image

Labetalol-structure. (Labetalol Structure)

Chemical structure diagram of labetalol hydrochloride, showing its molecular components including phenyl rings, hydroxyl, amide, and hydrochloride groups, consistent with the active ingredient labetalol hydrochloride.*

FDA Label Image

Table1 (Table1)

A data table comparing the incidence percentage of various side effects across four groups: Labetalol Hydrochloride, Placebo, Propranolol, and Metoprolol. The side effects are categorized by body systems including body as a whole, gastrointestinal, central and peripheral nervous systems, autonomic nervous system, cardiovascular, respiratory, skin, and special senses.*

FDA Label Image

Table2 (Table2)

A data table showing adverse event frequencies by percentage across different daily doses (mg) of Labetalol Hydrochloride. Columns list doses from 200 mg to 2400 mg with patient counts, and rows detail the occurrence of symptoms such as dizziness, fatigue, nausea, vomiting, dyspepsia, paresthesias, nasal stuffiness, ejaculation failure, impotence, and edema.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.